marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Pliant Therapeutics Financial Ratios 2011-2024 | PLRX
Annual Financial Ratios Pliant Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-6.3 | -9.6 | -3.3 | -21.0 | - | - | - | - | - | - | - | - | - |
P/S |
640.7 | 122.7 | 42.5 | 20.9 | - | - | - | - | - | - | - | - | - |
EPS |
-2.8 | -2.9 | -2.7 | -1.9 | -4.2 | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
988 M | 1.19 B | 292 M | 834 M | 33.7 M | 6.46 M | - | - | - | - | - | - | - |
EBITDA per Share |
-3.1 | -2.98 | -2.68 | -1.14 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
-2.7 | -20.4 | - | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.0 | - | - | - | - | - | - | - | - | - | ||
P/B |
2.1 | 3.8 | 1.6 | 3.1 | - | - | - | - | - | - | - | - | - |
P/CF |
-8.7 | -12.6 | -4.3 | -22.5 | - | - | - | - | - | - | - | - | - |
ROE % |
-34.07 | -39.36 | -48.86 | -14.67 | - | - | - | - | - | - | - | - | - |
ROA % |
-31.50 | -35.17 | -43.97 | -14.05 | - | - | - | - | - | - | - | - | - |
ROCE % |
-38.88 | -40.59 | -49.00 | -14.67 | - | - | - | - | - | - | - | - | - |
Current Ratio |
13.3 | 9.4 | 10.0 | 25.1 | - | - | - | - | - | - | - | - | - |
DSO |
- | 75.0 | 271.8 | 81.7 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 75.0 | 271.8 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 75.0 | 271.8 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Pliant Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.95 | -0.92 | -0.78 | - | -0.7 | -0.7 | -0.67 | - | -0.65 | -0.82 | -0.78 | - | -0.75 | -0.64 | -0.64 | - | -0.47 | -1.39 | - | - | -8.53 | -10.82 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.01 | -0.99 | -0.86 | - | -0.79 | -0.79 | -0.74 | - | -0.67 | -0.81 | -0.77 | - | -0.74 | -0.63 | -0.63 | - | -0.46 | -1.36 | 5.97 | - | -7.62 | -9.96 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-49.91 | -41.45 | -34.96 | -22.66 | -31.74 | -32.58 | -44.84 | -45.25 | -57.51 | -60.70 | -50.06 | -30.28 | -36.12 | -29.69 | -26.34 | -7.95 | 9.42 | 32.64 | 58.99 | 53.93 | 53.93 | 36.55 | 16.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-41.19 | -35.90 | -31.52 | -21.12 | -29.24 | -29.68 | -38.52 | -38.38 | -49.93 | -53.37 | -46.29 | -28.78 | -34.38 | -28.42 | -25.25 | -7.62 | -18.75 | -24.29 | -31.57 | -24.17 | -24.17 | -13.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-54.83 | -46.38 | -39.82 | -25.85 | -35.33 | -35.33 | -46.51 | -45.77 | -58.07 | -60.89 | -50.22 | -30.36 | -36.25 | -29.84 | -26.45 | -7.99 | 9.52 | 32.92 | 59.55 | 38.15 | 38.15 | 20.63 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.5 | 5.3 | 6.2 | 13.3 | 14.4 | 13.7 | 16.6 | 9.4 | 9.4 | 5.0 | 8.5 | 10.0 | 17.1 | 21.8 | 24.8 | 23.7 | 23.7 | 23.7 | 23.7 | 13.1 | 13.1 | 13.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | 897.2 | 180.9 | - | 199.2 | 57.0 | 118.6 | - | 97.5 | 102.1 | 240.4 | - | 175.9 | 235.2 | 25.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | 897.2 | 180.9 | - | 199.2 | 57.0 | 118.6 | - | 97.5 | 102.1 | 240.4 | - | 175.9 | 235.2 | 25.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | 897.2 | 180.9 | - | 199.2 | 57.0 | 118.6 | - | 97.5 | 102.1 | 240.4 | - | 175.9 | 235.2 | 25.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency